Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE
@BettyKimLab
Surgeon Scientist, Professor, Brain Tumor Surgeon, NIH and DOD Funded, #TwinMum, #AIMBE, #ASCI @MDAndersonNews, #Nanomedicine, #immunotherapy. Views are my own
Highlight of my career. James Allison @NobelPrize Medicine 2018, Phil Sharp @NobelPrize Medicine 1983, Carolyn Bertozzi @NobelPrize Chemistry 2022, @PamSharmaMDPhD #Mentor. #Inspiring. @MDAndersonNews #oncsurgery

📢 Read the full paper in Nature Cancer here: rdcu.be/ebeVG Deeply thankful to @BettyKimLab and @wenjiang_nano for their mentorship and support and all lab members @YWangPhD , @AnnetteWu9, @KristinHuntoon, @DYLee_BME , @DSYaN4 , @chang_mengyu, @adam_grippin , Yifan…
Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research. We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll #EndCancer
I’ve Joined @MDAndersonNews as an Assistant Professor and Physician-Scientist in Radiation Oncology - @BenjaminSchrank @BettyKimLab @ACKoongMDPhD oncodaily.com/blog/benjamin-… #RadiationOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #Immunotherapy #ImmuneOnc
Thrilled to share that I’ve joined @MDAndersonNews as an Assistant Professor & Physician-Scientist in Radiation Oncology--and I’m launching my lab! We’re building a research program at the intersection of genome instability, tumor immunology, and therapeutic development -- and…
Happy Father’s Day to the #BestDad in the world.

🎉 Excited to share in @NatRevImmunol a @yarmo111 @nyulangone study that dramatically expands the known repertoire of tumour-specific peptides for #tcelltherapies. Huge thanks to @BettyKimLab and the @preprintclub for the cross-instituional collaboration nature.com/articles/s4157…
Excited to moderate #GRC First Day Gordon Research Conference and our Airport Shuttle bus experienced slight technical issues…2 hours later almost had to hitchhike our way to #Tuscany. Looking forward to what this week will bring. #CancerNanomedicine

As we graduate our extraordinary fellows and residents, I am reminded of how little I knew when I thought I knew. From Highschool to Fellowship-Trained Neurosurgeon Scientist: 26 years.Thank you Mom, Dad, Wen, Hannah, teachers/mentors and our patients.


Thanks so much Kate for sharing all of your dolls with us! The collection is now complete with #Ariel and #Rapunzel @American_Girl @Disney

Partners today for #ACLS Saving lives with @BenjaminSchrank @MDAndersonNews

So grateful for our team and looking forward to what more we can accomplished. Check out our newest manuscript how we target the #STING pathway by #microbubbles and #ultrasound @lux_jacques @BettyKimLab @YWangPhD @UAZNeurosurgery advanced.onlinelibrary.wiley.com/doi/10.1002/ad…
Why do tumors evade immune detection, even when phagocytosed? - @BenjaminSchrank @BettyKimLab @MDAndersonNews @YWangPhD @DYLee_BME @AnnetteWu9 oncodaily.com/blog/benjamin-… #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate @MDAndersonNews @BenjaminSchrank @BettyKimLab Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to…
We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing such valuable content. oncodaily.com/blog/benjamin-…
Buckeroo breakfast with Daddy today. #NowWeAre5

MD Anderson researchers have developed a novel antibody toxin-conjugate that’s not designed to kill the cancer cells directly. Read how this new approach is designed to trigger the body's natural immune response instead: brnw.ch/21wQWWK #EndCancer
Thank you @ASCO for featuring our study: Novel Antibody-Toxin Conjugate Evaluated in Early Study Stay tuned as we work towards bringing this to our patients @MDAndersonNews @BenjaminSchrank @YWangPhD ascopost.com/news/february-…
Thanks @ACKoongMDPhD for your encouragement along the way. Your mentorship shapes the growth of trainees like myself @MDAndersonNews and beyond
Congrats @BenjaminSchrank on this study showing proof of concept that an antibody-toxin conjugate can be used to facilitate immune recognition of tumors. Very promising approach for the development of new cancer therapies! #endcancer @MDAndersonNews nature.com/articles/s4301…
Congrats @BenjaminSchrank on this study showing proof of concept that an antibody-toxin conjugate can be used to facilitate immune recognition of tumors. Very promising approach for the development of new cancer therapies! #endcancer @MDAndersonNews nature.com/articles/s4301…
Last day to vote for the AACR elections! Vote for Dr Yap even though he is a Liverpool fan!
Time is a ticking! The final vote deadline is Feb 25th. Tim has his flaws but he will wield the sword of AACR board wisely and justly-so vote for him!